We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NUVB market cap is 592.06M. The company's latest EPS is USD -1.6691 and P/E is -1.03.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.44M | 727k | 5.71M | 3.08M |
| Operating Income | -20.2M | -470.39M | -48.1M | -53.94M | -59M |
| Net Income | -14.79M | -462.49M | -41.21M | -49.45M | -53.24M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7.87M |
| Operating Income | -3.06M | -93.32M | -119.73M | -99.82M | -592.63M |
| Net Income | -3.05M | -86.85M | -104.2M | -75.8M | -567.94M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 613.13M | 594.8M | 571.58M | 540.63M | 492.49M |
| Total Liabilities | 19.08M | 62.67M | 68.87M | 76.84M | 73.03M |
| Total Equity | 594.04M | 257.19M | 502.71M | 463.79M | 419.46M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 145M | 776.15M | 672.14M | 621.48M | 540.63M |
| Total Liabilities | 2.8M | 30.15M | 17.07M | 16.36M | 76.84M |
| Total Equity | 5M | 746M | 655.08M | 605.12M | 463.79M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.7M | -53.03M | -84.11M | -130.41M | -42.63M |
| Investing | 7.54M | 41.82M | 70.93M | 122.7M | 54.18M |
| Financing | 21k | 2.77M | 1.23M | 331k | 548k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -701k | -68.19M | -96.11M | -68M | -130.41M |
| Investing | -143.75M | -454.67M | 63.46M | 8.92M | 122.7M |
| Financing | 145.36M | 625.53M | 1.33M | 628k | 331k |
| Market Cap | 592.06M |
| Price to Earnings Ratio | -1.03 |
| Price to Sales Ratio | 74.46 |
| Price to Cash Ratio | 16.38 |
| Price to Book Ratio | 1.26 |
| Dividend Yield | - |
| Shares Outstanding | 340.26M |
| Average Volume (1 week) | 11.57M |
| Average Volume (1 Month) | 6.75M |
| 52 Week Change | -40.41% |
| 52 Week High | 3.97 |
| 52 Week Low | 1.54 |
| Spread (Intraday) | 0.03 (1.71%) |
| Company Name | Panacea Acquisition Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ecor1cap.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
